Study | Reason for exclusion |
---|---|
Aaras 1998 | Non‐RCT |
Amick 2003 | Non‐RCT |
Amick 2012 | Non‐RCT |
Chau 2014 | Did not report neck and upper limb musculoskeletal outcome |
Danquah 2017 | > 25% of the participants reported neck‐shoulder pain at baseline (87/171; 50.9%) |
De Cocker 2016 | Did not report on neck and upper limb musculoskeletal outcome |
Driessen 2008 | Participants consisted of workers other than office workers: "Participants are workers, both blue and white collar workers, recruited from the departments of four large Dutch companies with at least 3,000 workers each". |
Dropkin 2015 | > 25% of the participants had musculoskeletal symptoms at baseline. "Additional inclusion criteria were: work at least 4 h/day on a desktop computer, non‐specific neck/ UE musculoskeletal pain (1 or greater on the pain scale described below) at the time of screening". |
Esmaeilzadeh 2014 | > 25% of the participants had musculoskeletal symptoms at baseline. Study only included participants with Work‐related upper extremity musculoskeletal symptoms (WUEMSS); " ... case definition criteria, 94 of the 311 respondents had WUEMSS and were subsequently included in the interventional study". |
Faucett 2002 | Study was not conducted in an office environment |
Fostervold 2006 | > 25% of the participants had neck and shoulder symptoms at baseline. The prevalence of neck and shoulder symptoms at baseline was 73.5% in the intervention group and 75% in the comparison group. |
Ketola 2002 | > 25% of the participants had neck and shoulder symptoms at baseline. The study included subjects with musculoskeletal symptoms: "One hundred and twenty‐four subjects with musculoskeletal symptoms were selected". |
Krause 2010 | Did not report on neck and shoulder musculoskeletal symptoms |
Levanon 2012 | > 25% of the participants had musculoskeletal symptoms at baseline; "as all the participants have at least 1 part of the UE with complaints of pain at baseline". |
Mahmud 2011 | > 25% of the participants had musculoskeletal symptoms at baseline. The prevalence for of musculoskeletal disorder at baseline for intervention and control groups ranged from 16.3% ‐ 63.6%. |
Mann 2013 | > 25% of the participants had musculoskeletal symptoms at baseline; "The inclusion criteria of this study was pain, stiffness or tingling in neck and shoulder in the preceding six months affecting the quality of activities of daily living". |
Meijer 2009a | > 25% of the participants had upper extremity musculoskeletal symptoms at baseline. Prevalence for the control group was 49% and 36% for the intervention group. |
Meijer 2009b | > 25% of the participants had musculoskeletal symptoms at baseline; 33.3% of the participants have UE complaints at baseline. |
Mekhora 2000 | > 25% of the participants had musculoskeletal symptoms at baseline; Participants consisted of those with symptoms of above average discomfort: "That is, those with above average discomfort and who had discomfort around the neck and shoulder areas for more than 1 day in the previous year were selected". |
Parry 2015 | > 25% of the participants had upper extremity musculoskeletal symptoms at baseline. The prevalence of participants reporting musculoskeletal pain in different body regions at baseline ranged from 28‐60%. |
Ripat 2006 | > 25% of the participants had musculoskeletal symptoms at baseline; "The study population were workers who reported had two or more symptoms of WRUED (i.e. paraesthesia,numbness, loss of strength, shooting sensation or pain, tingling, clumsiness, or night pain)". |
Robertson 2013 | The intervention was conducted in an laboratory setting, the participants were not performing actual/routine work. |
Spekle 2010 | > 25% of the participants had musculoskeletal symptoms at baseline; Prevalence of symptoms ‐ 56% , Proximal Symptoms ‐ 46% , Distal Symptoms ‐ 26% at baseline. |
Thorp 2014 | The intervention was conducted in an laboratory setting, the participants were not performing actual/routine work. |
RCT: randomised controlled trial.